Dr. Reddy's Laboratories share price: Jefferies Maintains Buy rating on the stock
Jefferies channel checks indicate API supply constraints for generic manufacturers of Vascepa. Amarin has added EU and China as new markets, thereby committing more volumes to its regular API vendor base. CCSB Taiwan has been the sole/key API supplier for both Hikma and Dr. Reddy's and is currently facing scale-up challenges.
Jefferies cuts Dr. Reddy's Laboratories FY22E EPS by 1%. Maintain Buy rating on Dr. Reddy's Laboratories: Reuters